Literature DB >> 21174181

Aberrant cytoplasmic expression of cyclin B1 protein and its correlation with EBV-LMP1, P53 and P16(INK4A) in classical Hodgkin lymphoma in China.

Po Zhao1, Yali Lu, Lin Liu, Mei Zhong.   

Abstract

The relationships between the expression of cyclin B1, EBV-LMP1, P53 and P16(INK4A) in Chinese classical Hodgkin lymphoma are unknown and need exploring. Samples of classical Hodgkin lymphoma from 60 Chinese patients were analyzed for the expression of cyclin B1, EBV-LMP1, P53 and P16(INK4A) proteins by immunohistochemistry. Cyclin B1 protein was overexpressed in 90.0% (54/60) of this group of classical Hodgkin lymphoma, staining mainly and strongly in cytoplasm but also sparsely and weakly in nucleus of the Hodgkin and Reed-Sternberg (HRS) cells. EBV-LMP1, P53 and P16(INK4A) were overexpressed in 85.0%, 96.7% and 71.7% of Hodgkin lymphoma, respectively. EBV-LMP1, P53 and P16(INK4A) were was noted in the nucleus of HRS cells. Microscopically, cyclin B1 and P53 staining distinguished the HRS cells from the complex background of lymphocytes. Cyclin B1 was positively correlated with EBV-LMP1(P < 0.001) and P53(P < 0.001), but was inversely related to P16(INK4A) (P < 0.05). It is suggested that overexpression of cyclin B1 could play an important role in the evolution of classical Hodgkin lymphoma, and cyclin B1 may be considered as a potential adjunct marker to identify HRS cells in diagnosis and be served as Hodgkin lymphoma-associated antigen in the near future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21174181     DOI: 10.1007/s12253-010-9335-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  19 in total

1.  Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis.

Authors:  Lisa A Porter; I Howard Cukier; Jonathan M Lee
Journal:  Blood       Date:  2002-11-07       Impact factor: 22.113

2.  cdc2/cyclin B1-dependent phosphorylation of EBNA2 at Ser243 regulates its function in mitosis.

Authors:  Wei Yue; Julia Shackelford; Joseph S Pagano
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53.

Authors:  Min Yu; Qimin Zhan; Olivera J Finn
Journal:  Mol Immunol       Date:  2002-05       Impact factor: 4.407

Review 4.  The cyclin-dependent protein kinases and the control of cell division.

Authors:  M Dorée; S Galas
Journal:  FASEB J       Date:  1994-11       Impact factor: 5.191

5.  Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.

Authors:  J C Soria; S J Jang; F R Khuri; K Hassan; D Liu; W K Hong; L Mao
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

6.  Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.

Authors:  M Bai; J Vlachonikolis; N J Agnantis; E Tsanou; S Dimou; C Nicolaides; S Stefanaki; N Pavlidis; P Kanavaros; P Kanavarous
Journal:  Mod Pathol       Date:  2001-11       Impact factor: 7.842

7.  T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease.

Authors:  Hiroyuki Suzuki; Daniel F Graziano; John McKolanis; Olivera J Finn
Journal:  Clin Cancer Res       Date:  2005-02-15       Impact factor: 12.531

8.  Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological study.

Authors:  Mitsuhiro Yasuda; Fumio Takesue; Sadaaki Inutsuka; Masayuki Honda; Tadahiro Nozoe; Daisuke Korenaga
Journal:  J Cancer Res Clin Oncol       Date:  2002-07-26       Impact factor: 4.553

9.  CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53.

Authors:  Rikke Baek Sørensen; Rikke Sick Andersen; Inge Marie Svane; Lotte Engell-Noerregaard; Sine R Hadrup; Eva Balslev; Mads Hald Andersen; Per thor Straten
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

10.  Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1.

Authors:  J Yang; E S Bardes; J D Moore; J Brennan; M A Powers; S Kornbluth
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

View more
  1 in total

1.  Epstein-Barr virus infection correlates with the expression of COX-2, p16(INK4A) and p53 in classic Hodgkin lymphoma.

Authors:  Suhail Al-Salam; Aktham Awwad; Manjusha Sudhadevi; Sayel Daoud; Nico J D Nagelkerke; Antonio Castella; S M Chong; Mouied Alashari
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.